Is surgery recommended for Stomach Cancer and when

Surgery for Stomach Cancer: When and Why

Yes, surgery is a cornerstone treatment for stomach cancer, but when it's recommended depends heavily on the stage of your cancer and your overall health.

THE GENERAL APPROACH

According to the NCCN Guidelines for Gastric Cancer, surgery is typically the primary treatment goal for patients with stomach cancer who are medically fit (able to tolerate major surgery). However, the timing and type of surgery varies significantly based on your specific situation.

SURGERY RECOMMENDATIONS BY STAGE

Early-Stage Disease (T1a or T1b)

For very early cancers confined to the innermost layers of the stomach:

• Endoscopic resection (ER) may be an option—this is a minimally invasive procedure where the tumor is removed through the mouth using an endoscope
• This approach can be both diagnostic AND therapeutic (meaning it both stages the cancer accurately and removes it)
• Traditional surgery may also be recommended depending on other factors

Locally Advanced Disease (T2 or Higher)

For cancers that have grown deeper into the stomach wall or involve lymph nodes:

• Surgery is typically recommended as the primary treatment for medically fit patients
• Often combined with perioperative systemic therapy (chemotherapy given before and/or after surgery) to improve outcomes
• For patients with MSI-H/dMMR tumors (specific genetic markers), immunotherapy may be considered alongside surgery

Unresectable or Metastatic Disease

When the cancer cannot be completely removed or has spread:

• Surgery may still be considered for palliative purposes (to relieve symptoms like bleeding or obstruction)
• Systemic therapy (chemotherapy or immunotherapy) becomes the primary treatment
• Best supportive care focuses on quality of life

PREOPERATIVE THERAPY (Surgery After Chemotherapy)

An important concept in modern stomach cancer treatment is neoadjuvant therapy—giving chemotherapy BEFORE surgery to:

• Shrink the tumor and make it easier to remove completely
• Improve long-term survival outcomes
• According to NCCN Guidelines, perioperative systemic therapy is a Category 1 recommendation (highest level of evidence) for medically fit patients with resectable disease

WHAT DETERMINES IF YOU'RE A SURGICAL CANDIDATE?

Your doctors will evaluate:

• Your overall health (ability to tolerate major surgery)
• Tumor stage (how far it has spread)
• Tumor location (cardia, fundus, body, antrum)
• Extent of lymph node involvement
• Presence of distant metastases (spread to other organs)
• Performance status (your functional ability)

KEY QUESTIONS TO ASK YOUR ONCOLOGY TEAM

1. Based on my staging scans and pathology, is my cancer resectable (can it be completely removed)?

2. Am I medically fit for surgery, and what does that evaluation involve?

3. Would you recommend chemotherapy before surgery (neoadjuvant therapy), and if so, for how long?

4. What type of surgical procedure would be performed (partial or total gastrectomy), and what are the expected outcomes?

5. If my cancer is unresectable, what are the treatment options to manage symptoms and extend survival?

6. Do I have any specific biomarkers (MSI-H/dMMR, HER2, CLDN18.2) that might change the treatment approach?

IMPORTANT CONTEXT

According to the NCCN Guidelines, the goal of surgery is typically an R0 resection—meaning all visible cancer is removed with negative margins (no cancer cells at the edges). The extent of lymph node removal (D2 dissection) also impacts outcomes and is an important part of the surgical plan.

The combination of surgery with systemic therapy has significantly improved survival rates for stomach cancer patients compared to surgery alone, which is why your multidisciplinary team (surgeon, medical oncologist, and other specialists) will work together to create your personalized treatment plan.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.